Prospective Cohort of Patients Treated Using Neoadjuvant Modified FOLFIRINOX 6 Cycles for Potentially Resectable Pancreatic Duct Adenocarcinoma, Candidate for Participation in the PANACHE02 Clinical Trial

NCT07034703 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
820
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University Hospital, Rouen

Collaborators